Follow The Filings

ZNTL position history

The shares of Zentalis Pharmaceuticals (ZNTL) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2022 Q4: 167,500 shares, $3.4M, 1.2% of portfolio, New
  2. 2023 Q1: not held, Exit
  3. 2023 Q2: not held
  4. 2023 Q3: not held
  5. 2023 Q4: not held
  6. 2024 Q1: 400,000 shares, $6.3M, 1.4% of portfolio, New
  7. 2024 Q2: not held, Exit
  8. 2024 Q3: 967,000 shares, $3.6M, 0.59% of portfolio, New
  9. 2024 Q4: 1,767,500 shares, $5.4M, 0.94% of portfolio, Add +82.8%
  10. 2025 Q1: 1,985,000 shares, $3.2M, 0.70% of portfolio, Add +12.3%
  11. 2025 Q2: 3,848,600 shares, $4.5M, 0.90% of portfolio, Add +93.9%
  12. 2025 Q3: 316,550 shares, $478K, 0.07% of portfolio, Reduce −91.8%
  13. 2025 Q4: 2,801,812 shares, $3.8M, 0.50% of portfolio, Add +785.1%
  14. 2026 Q1: 1,412,656 shares, $3.3M, 0.44% of portfolio, Reduce −49.6%
  15. 2026 Q2: 1,412,656 shares, $6.9M, 0.62% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders